Article info

Download PDFPDF

009 Predicting infection risk in multiple sclerosis patients treated with ocrelizumab: a retrospective cohort study
Free

Authors

  • Nabil Seery Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Sifat Sharmin Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia Clinical Outcomes Research Unit, The University of Melbourne, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Vivien Li Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Florey Institute of Neurosciences and Mental Health, The University of Melbourne, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Ai-Lan Nguyen Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia Clinical Outcomes Research Unit, The University of Melbourne, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Claire Meaton Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Roberts Atvars Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Nicola Taylor Day Medical Centre, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Kelsey Tunnell Day Medical Centre, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Joh Carey Day Medical Centre, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Mark P Marriott Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Department of Neuroscience, Eastern Health Clinical School, Box Hill, VIC, Australia PubMed articlesGoogle scholar articles
  • Katherine A Buzzard Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Department of Neuroscience, Eastern Health Clinical School, Box Hill, VIC, Australia PubMed articlesGoogle scholar articles
  • Izanne Ross Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia Clinical Outcomes Research Unit, The University of Melbourne, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Chris Dwyer Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Florey Institute of Neurosciences and Mental Health, The University of Melbourne, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Josephine Baker Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Lisa Taylor Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Kymble Springs Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia Department of Immunology, The Royal Melbourne Hospital, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Trevor J Kilpatrick Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Florey Institute of Neurosciences and Mental Health, The University of Melbourne, Parkville, VIC, Australia PubMed articlesGoogle scholar articles
  • Tomas Kalincik Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia Clinical Outcomes Research Unit, The University of Melbourne, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles
  • Mastura Monif Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia MS and Neuroimmunology Department, Alfred Health, Melbourne, VIC, Australia Department of Neuroscience, Monash University, Melbourne, VIC, Australia PubMed articlesGoogle scholar articles

Citation

Seery N, Sharmin S, Li V, et al
009 Predicting infection risk in multiple sclerosis patients treated with ocrelizumab: a retrospective cohort study

Publication history

  • First published August 23, 2021.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.